Nitric oxide synthase inhibitors

Area of Science:

• Biomedical Science
• Pharmacology
• Physiology

Background:

• In 1990, research linked increased endogenous nitric oxide (NO) to endotoxin-induced hypotension and tumor-necrosis factor-α (TNFα) effects.
• Overproduction of NO was identified as a key factor in the vascular hyporesponsiveness (vasoplegia) observed in shock states.
• Subsequent research has focused on nitric oxide synthase (NOS) inhibitors in animal models of shock.

Purpose of the Study:

• To review the physiological roles of nitric oxide (NO).
• To examine the beneficial and detrimental roles of NO in septic shock.
• To provide a foundation for discussing the pharmacology of NOS inhibitors.

Main Methods:

• Literature review of studies published since 1990.
• Analysis of animal models of septic shock.
• Examination of the effects of nitric oxide synthase (NOS) inhibitors.

Main Results:

• Endogenous NO production is a significant contributor to hypotension in endotoxin shock.
• NO overproduction plays a critical role in the pathophysiology of vasoplegia.
• Research has extensively investigated NOS inhibitors in various shock models.

Conclusions:

• Nitric oxide (NO) has multifaceted roles in septic shock, with both beneficial and detrimental effects.
• Understanding NO's physiology is crucial for developing effective treatments for shock.
• NOS inhibitors are a key area of research for managing septic shock.